Stockscreener 앱 받기
3.15
0.32%
-0.01
시간 외 거래:
3.32
0.17
+5.40%
전일 마감가:
$3.16
열려 있는:
$3.16
하루 거래량:
94,791
Relative Volume:
0.27
시가총액:
$37.94M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
+3.96%
1개월 성능:
-10.76%
6개월 성능:
-92.14%
1년 성능:
+0.00%
1일 변동 폭
$3.08
$3.21
1주일 범위
$2.90
$3.46
52주 변동 폭
$2.90
$53.79
Q 32 Bio Inc Stock (QTTB) Company Profile
명칭
Q 32 Bio Inc
전화
781-999-0232
주소
830 WINTER STREET, WALTHAM
QTTB을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
QTTB
Q 32 Bio Inc
|
3.15 | 37.94M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.32 | 122.13B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
710.00 | 78.30B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
646.64 | 39.73B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
276.19 | 35.50B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
117.61 | 28.47B | 3.30B | -501.07M | 1.03B | -2.1146 |
Q 32 Bio Inc Stock (QTTB) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-12-11 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2024-12-11 | 다운그레이드 | Leerink Partners | Outperform → Market Perform |
| 2024-12-11 | 다운그레이드 | Raymond James | Strong Buy → Outperform |
| 2024-12-11 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2024-12-06 | 개시 | BMO Capital Markets | Outperform |
| 2024-10-24 | 개시 | Raymond James | Strong Buy |
| 2024-09-11 | 개시 | Wells Fargo | Overweight |
| 2024-06-17 | 개시 | Guggenheim | Buy |
| 2024-05-21 | 개시 | Leerink Partners | Outperform |
| 2024-04-11 | 개시 | Oppenheimer | Outperform |
| 2024-04-02 | 개시 | Piper Sandler | Overweight |
| 2023-07-28 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2022-02-22 | 재확인 | BTIG Research | Neutral |
| 2022-02-22 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2022-02-22 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2021-03-02 | 개시 | Stifel | Hold |
| 2020-12-14 | 재개 | H.C. Wainwright | Buy |
| 2020-08-11 | 재확인 | H.C. Wainwright | Buy |
| 2020-06-25 | 재개 | BofA/Merrill | Buy |
| 2020-05-13 | 개시 | RBC Capital Mkts | Outperform |
| 2020-03-16 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2020-02-24 | 개시 | Chardan Capital Markets | Buy |
| 2019-11-01 | 개시 | Oppenheimer | Perform |
| 2019-09-10 | 개시 | Robert W. Baird | Outperform |
| 2019-04-12 | 개시 | Evercore ISI | Outperform |
모두보기
Q 32 Bio Inc 주식(QTTB)의 최신 뉴스
Q32 Bio to Participate in Oppenheimer's 35th Annual Healthcare Life Sciences Conference - The Eastern Progress Online
QTTB stock touches 52-week low at $2.95 amid market challenges - MSN
Barclays PLC Acquires 5,353 Shares of Q32 Bio Inc. (NASDAQ:QTTB) - Defense World
Q32 Bio Inc. (NASDAQ:QTTB) Receives $29.86 Consensus Target Price from Brokerages - Defense World
Q32 Bio Advances Clinical Trials for Growth Opportunities - TipRanks
Pre-market Movers: ONCO, EYEN, SGMO, VSTM... - RTTNews
Q32 Bio Inc (QTTB) Could Be Worth Considering For The Next Few Weeks - Stocks Register
Arq Inc (ARQ) Analyst Thoughts: How High Can It Go? - Stocks Register
Analysts Update Their Estimates For Brunswick Corp - Stocks Register
At $1.81 Price, XCHG Ltd ADR (XCH) Is Sitting And Waiting - Stocks Register
Analysts Update Their Estimates For EPR Properties - Stocks Register
Protagenic Therapeutics Inc’s (PTIX) -12.44% Retreat Justifies A Second Look - Stocks Register
LegalZoom.com Inc (LZ) Volatility Hits 3.83% – Here Is What You Should Do - Stocks Register
At $18.67 Price, Osisko Gold Royalties Ltd (OR) Is Sitting And Waiting - Stocks Register
First Foundation Inc (FFWM): A New Perspective - Stocks Register
Analyst Updating Price Targets And Ratings For Springview Holdings Ltd (SPHL) - Stocks Register
QTTB Stock Touches 52-Week Low at $3 Amid Market Challenges - Investing.com India
QTTB Stock Touches 52-Week Low at $3 Amid Market Challenges By Investing.com - Investing.com South Africa
What You Didn’t Know About Chipotle Mexican Grill (NYSE: CMG) This Week - Stocks Register
Q32 Bio (QTTB) Upgraded to Buy: What Does It Mean for the Stock? - MSN
Pre-market Movers: CDT, NARI, GDTC, NARI... - RTTNews
Geode Capital Management LLC Purchases 24,114 Shares of Q32 Bio Inc. (NASDAQ:QTTB) - Defense World
Jane Street Group LLC Acquires New Stake in Q32 Bio Inc. (NASDAQ:QTTB) - Defense World
Q32 Bio Inc. (NASDAQ:QTTB) Holdings Increased by Barclays PLC - Defense World
Franklin Resources Inc. Takes Position in Q32 Bio Inc. (NASDAQ:QTTB) - Defense World
NuScale Power Corporation (NYSE: SMR): An Enticing Stock To Watch - Stocks Register
Q32 Bio Inc. (NASDAQ:QTTB) Shares Bought by State Street Corp - Defense World
ARS Pharmaceuticals (NASDAQ:SPRY) vs. Q32 Bio (NASDAQ:QTTB) Head to Head Review - Defense World
Q32 Bio Inc. (NASDAQ:QTTB) Receives $29.86 Consensus Target Price from Analysts - Defense World
Here's Why Q32 Bio Stock Hit a New Record Low on Wednesday - MSN
Q32 Bio: Oppenheimer slashes price target on mixed trial results - MSN
Q32 Bio's SWOT analysis: stock outlook shifts amid clinical setbacks By Investing.com - Investing.com Canada
Q32 Bio's SWOT analysis: stock outlook shifts amid clinical setbacks - Investing.com India
Q32 Bio pushes back Phase 2 trial of ADX-097 in AAV patients - ANCA Vasculitis News
StockWatch: Q32 Shares Crater 85% as Investors, Analysts Sour on Trial Results - Genetic Engineering & Biotechnology News
BMO Capital Markets Cuts Q32 Bio (NASDAQ:QTTB) Price Target to $22.00 - Defense World
Q32 Bio FY2025 EPS Estimate Lifted by Leerink Partnrs - Defense World
FY2025 EPS Estimates for Q32 Bio Boosted by Leerink Partnrs - MarketBeat
Q32 Bio shares target cut, rating held on clinical trial results - Investing.com Canada
Here's Why Q32 Bio Stock Hit A New Record Low On Wednesday - Barchart
Q32 Bio (NASDAQ:QTTB) Rating Lowered to Hold at Leerink Partnrs - MarketBeat
Q32 Bio price target lowered to $20 from $80 at Oppenheimer - Yahoo Finance
Candel leads biotech gainers amid wave of data readouts - BioCentury
QTTB Stock Touches 52-Week Low at $8.06 Amid Market Volatility - Investing.com India
Leerink revises Q32 Bio stock target as Phase 2 trials fail to meet expectations - Investing.com Canada
Q32 Bio stock target cut, rating held on trial results By Investing.com - Investing.com Nigeria
Q32 Bio shares downgraded as Ph2 trials reveal limited near-term upside potential - Investing.com Nigeria
Q32 stock craters 71% on mixed Phase 2 data for bempikibart (NASDAQ:QTTB) - Seeking Alpha
Q32 Bio stock target cut, rating held on trial results - Investing.com
Oppenheimer maintains Outperform on Q32 Bio stock with focus on renal basket study - Investing.com
Why Is Skin Disease-Focused Q32 Bio Stock Trading Lower On Wednesday? - Benzinga
Q 32 Bio Inc (QTTB) 재무 분석
Q 32 Bio Inc (QTTB)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
Q 32 Bio Inc 주식 (QTTB) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Violette Shelia M. | Chief Scientific Officer |
Oct 11 '24 |
Option Exercise |
3.12 |
4,574 |
14,271 |
17,874 |
| Violette Shelia M. | Chief Scientific Officer |
Oct 08 '24 |
Option Exercise |
3.12 |
13,300 |
41,496 |
13,300 |
| TZIANABOS ARTHUR | Director |
Mar 25 '24 |
Sale |
24.20 |
265 |
6,413 |
7,983 |
| Alloway Paul | See Remarks |
Mar 25 '24 |
Sale |
24.21 |
268 |
6,488 |
2,596 |
| Michaud Charles Jr | See Remarks |
Mar 25 '24 |
Sale |
24.20 |
75 |
1,815 |
927 |
1.09%
자본화:
|
볼륨(24시간):